Tango Therapeutics Inc (NASDAQ:TNGX) shares, rose in value, with the stock price up by 0.78% to the previous day’s close as strong demand from buyers drove the stock to $1.29.
Actively observing the price movement in the last trading, the stock closed the session at $1.28, falling within a range of $1.27 and $1.33. The value of beta (5-year monthly) was 1.033. Referring to stock’s 52-week performance, its high was $12.02, and the low was $1.11. On the whole, TNGX has fluctuated by -25.22% over the past month.
With the market capitalization of Tango Therapeutics Inc currently standing at about $139.46 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-26.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 29.09M, with a low estimate of 4.32M and a high estimate of 8.34M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 6.73M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that TNGX’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of TNGX currently trading nearly -8.51% and -31.87% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 37.64, while the 7-day volatility ratio is showing 9.60% which for the 30-day chart, stands at 11.67%. Furthermore, Tango Therapeutics Inc (TNGX)’s beta value is 1.03, and its average true range (ATR) is 0.16.
A comparison of Tango Therapeutics Inc (TNGX) with its peers suggests the former has fared considerably weaker in the market. TNGX showed an intraday change of 0.78% in last session, and over the past year, it shrunk by -82.45%%.
Data on historical trading for Tango Therapeutics Inc (NASDAQ:TNGX) indicates that the trading volumes over the past 10 days have averaged 0.61 and over the past 3 months, they’ve averaged 728.28K. According to company’s latest data on outstanding shares, there are 107.73 million shares outstanding.
Nearly 45.31% of Tango Therapeutics Inc’s shares belong to company insiders and institutional investors own 56.02% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 10.04 million shares as on 2025-03-31, resulting in a short ratio of 10.88. According to the data, the short interest in Tango Therapeutics Inc (TNGX) stood at 1702.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 7.04 million. The stock has fallen by -58.25% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TNGX stock heading into the next quarter.
